3 assets in Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

Therapeutic assets addressing Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Bcma-Cd19 Ccar T Cells Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis	Peking University People's Hospital	P2	CCC (53)
Ucar T-Cell Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis	The Children's Hospital of Zhejiang University School of Medicine	P1	CCC (50)
qt-219cx Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis	The Children's Hospital of Zhejiang University School of Medicine	Early P1	C (39)